Tizanidine Hydrochloride
Product Images NDC 42549-549

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 42549-549). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Paneltizanidine 2mg, 28 Tablets (Tizanidine 2 mg Label 42549)

The text seems to describe a packaged medication containing 2.288mg of Tizanidine. The manufacturer is Sandoz and the product has a National Drug Code (NDC) of 42549-549-30. The medication is distributed in tablets and contains 1 to 2mg of the active ingredient. The medication's lot number is 27384 and it should be discarded by May 15th, 2012. The rest of the text appears to be garbled and not usable.*

FDA Label Image

Principal Display Paneltizanidine 4mg, 28 Tablets (Tizanidine 4 mg Label 42549)

This appears to be a description of a medication containing tizanidine in tablet form. The medication is packaged and distributed by BSTAT in Gainesville, USA. Each tablet contains 4.576mg of tizanidine, which is equivalent to 4mg of tizanidine base. It has a lot number of GRXISO0 and an expiration date of 03/13 by 11/29/2011. The medication may cause drowsiness, and consuming alcohol while taking it is not recommended. However, it is unclear what the text meant by "Vesu abexoed o" since it is not a readable text in any known language.*

FDA Label Image

Chemical Structure (Tizanidine Chem Structure)

FDA Label Image

Figure 1 (Tizanidine 2)

The text describes a graph showing plasma Tizanidine concentration level in milligrams per milliliter over time. The x-axis represents the time in hours after dosing, and the y-axis represents the concentration level. The text also provides information on dosing, specifying that two 4 mg Tizanidine tablets can be taken with or without food.*

FDA Label Image

Figure 2 (Tizanidine 3)

The text describes a graph showing the Improvement in Ashworth Score after taking either 16 mg or 8 mg tizanidine or placebo at different hours post-dose. No other information is available.*

FDA Label Image

Figure 3 (Tizanidine 4)

The text describes the improvement in Ashworth Score for Tizanidine versus a placebo during a clinical trial with a mean dose of 28.8 mg. It specifies the observation points: end of titration, end of maintenance, and endpoint.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.